Search
 
1    2    3    4   
Press Releases
Aug 27, 2015
Generex Announces Issuance of Buccal Insulin White Paper
Aug 25, 2015
Generex Provides Update on Success of Buccal Insulin Formulation Enhancement Project
Jun 24, 2015
Generex Announces Capital Investment
All releases
Webcast Events and Media
 

Print Print     Email Email page

Investor Home


Investor Relations

For more information please contact:
Todd Falls
Tel: 1-800-391-6755
Fax: (647) 547-7104
Email: tfalls@generex.com


Exchange

OTC Bulletin Board

Listed Security

GNBT Common Stock

Transfer Agent

StockTrans, Inc.
44 West Lancaster Avenue
Ardmore, PA 19003
Phone 610-649-7300
Fax 610-649-7302

Corporate Counsel

Eckert Seamans Cherin & Mellott, LLC
1515 Market Street, 9th Floor
Philadelphia, PA 19102
Phone 215-851-8447
Fax 215-851-8383


Stock Quote
OTC BB: GNBT        0.01 + 0.00
28 Aug 2015    3:53 PM ET
Investor Tool Kit
PDF Corporate Fact Sheet
PDF Investor Presentation

Privacy Policy